THC.CSE THCBF – OTC TFHC.F
Vancouver, British Columbia – (February 25, 2020)
THC BioMed Intl Ltd. (CSE: THC), (“THC” or the “Company“) is pleased to announce that its Annual General and Special Meeting of shareholders (the “Meeting”) was held in Vancouver, British Columbia on February 25, 2020. The Company is pleased to report that all matters submitted to shareholders for approval as set out in the Company’s Notice of Meeting and Information Circular, filed on January 20, 2020 and available on www.sedar.com, were approved.
“I would like to thank the Company’s shareholders for their continued support,” said John Miller, President and CEO of THC. “Management continues to work hard on the consistent growth of the Company and we are excited for the future of THC.”
About THC
THC BioMed is a Cannabis Act Licensed Producer of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. THC BioMed is Canada’s largest supplier of legal cannabis genetics. The Company is on the leading edge of scientific research and the development of products and services related in the medical cannabis industry. Management believes THC BioMed is well-positioned to be in the forefront of this rapidly growing industry.
President and CEO: John Miller
THC Biomed Intl Ltd.
T: 1-844-THCMEDS
E: info@thcbiomed.com
Forward-Looking Information:
This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of THC. Forward-looking information is based on certain key expectations and assumptions made by the management of THC. In some cases, you can identify forward-looking statements by the use of words such as “will,” “may,” “would,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “likely,” “could” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Although THC believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because THC can give no assurance that they will prove to be correct. Forward-looking statements contained in this press release are made as of the date of this press release and include that THC will be at the forefront of this rapidly growing industry.
The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.